Featured

Exploring the latest advances in first-line treatment of ES-SCLC



Published
Leading lung cancer experts Dr Marina Garassino, Dr Luis Paz-Ares and Dr Martin Edelman share their perspectives on recent advances in the first-line treatment of ES-SCLC, the safety profiles of immunochemotherapies, how to manage side effects and more.

Watch now: https://touchoncology.com/cme/es-sclc-first-line-treatment/

-------------
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
Category
Health
Be the first to comment